• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY:ASX)

    9.000 +0.000 (+0.00%)
    Streaming Delayed Price Updated: 10:07 AM EDT, May 7, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about ASE Technology Holding Co., Ltd. American Depositary Shares (each representing

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
    ATH434 Phase 2 Data to be Presented at Opening Plenary Session 
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Appendix 4C – Q3 FY25 Quarterly Cash Flow Report
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Earnings Scheduled For April 30, 2025
    Via Benzinga
    P/E Ratio Insights for ASE Technology Holding Co
    Via Benzinga
    Earnings Scheduled For February 13, 2025
    Via Benzinga
    Current Report ASE Technology
    Share price rose about 19% in the past year from $8.59 to $10.21, as of Friday’s market close. 
    Via Talk Markets
    Topics Stocks / Equities
    Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    ASE Technology Holding Co Honors Outstanding Suppliers of 2024
    From ASE Technology Holding Co., Ltd.
    Via Business Wire
    Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics to Deliver an Oral Presentation of the Positive ATH434 Phase 2 Trial Results at the American Academy of Neurology Annual Meeting
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    ASE Demonstrates CPO that Improves Energy Efficiency for AI applications
    From Advanced Semiconductor Engineering, Inc.
    Via Business Wire
    Alterity Therapeutics Completes Last Patient Visit in ATH434-202 Open-Label Phase 2 Trial in Multiple System Atrophy
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Oil & Gas Virtual Investor Conference Agenda Announced for March 27th
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Life360 Adds a Touch of Kawaii With Tile X Hello Kitty®, a Limited-Edition Collection in Partnership With Sanrio
    Hello Kitty® Adds Her Supercute Charm to a Specially Designed Lineup of Bluetooth Trackers, Tile Mate and Tile Slim, Available Starting March 20 
    From Life360, Inc.
    Via GlobeNewswire
    Life360 Appoints Former Amazon Cybersecurity Lead Vari Bindra as Chief Information Security Officer
    Newly-created role underscores company’s commitment to safeguarding the digital well-being of millions of families worldwide 
    From Life360, Inc.
    Via GlobeNewswire
    Baker Hughes and Woodside Energy Announce Collaboration Framework to Develop Small-Scale Decarbonization Solution Utilizing Net Power Platform
    From Baker Hughes
    Via GlobeNewswire
    Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia
    – Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales – 
    From Esperion Therapeutics, Inc.
    Via GlobeNewswire
    Life360 Reports Record Q4 and FY 2024 Results
    From Life360, Inc.
    Via GlobeNewswire
    Life360 Enhances Advertising Capabilities with Strategic Acquisition of Fantix’s AdTech AI Platform
    AI Data Science platform will empower smarter, targeted advertising solutions while preserving privacy 
    From Life360, Inc.
    Via GlobeNewswire
    ASE Technology Expands In Malaysia: New High-Tech Chip Facility Boosts Semiconductor Growth
    ASE Technology Holding opens new chip packaging and testing facility in Penang, Malaysia, boosting the country's role in global semiconductor industry. 
    Via Benzinga
    ASE Expands its Chip Packaging and Testing Facility to Enable Next-Gen Applications
    From Advanced Semiconductor Engineering, Inc.
    Via Business Wire
    Alterity Therapeutics Raises A$40.0 million in Placement
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Life360 to Announce Q4 and Full Year 2024 Financial Results on February 27, 2025
    From Life360, Inc.
    Via GlobeNewswire
    Dotz Nano to Present at the Small Cap Growth Virtual Investor Conference February 6th
    Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Trump Says Its Time For US To 'Return' To A System That Made It Rich And Powerful As The President Proposes Tariffs On Taiwan: 'Bring Production Back To Our Country'
    President Donald Trump's pledge to impose sweeping tariffs on imports from Taiwan is raising concerns across semiconductor and pharmaceutical industries, particularly affecting Taiwan Semiconductor... 
    Via Benzinga
    Topics Government World Trade
    Exposures Political Tariff
    Appendix 4C – Q2 FY25 Quarterly Cash Flow Report
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.